Fly Intel: Top five weekend stock stories

Catch up on the weekend's top five stories with this list compiled by The Fly: 1. Grab Holdings CEO Anthony Tan said he's confident the merger of the ride-hailing and food-delivery giant and a U.S. blank-check company will be completed by year-end, following a delay caused by a review of its financials, Bloomberg's Yoolim Lee and Juliette Saly reported. The Singapore-based startup last week postponed the expected completion of the deal with Altimeter Growth Corp. (AGC) - set to be one of the largest-ever mergers with a special purpose acquisition company - to the fourth quarter as it works on an audit of the past three years, the authors noted. 2. Tesla's (TSLA) CEO Elon Musk said via Twitter that, " Tesla only sold ~10% of holdings to confirm BTC could be liquidated easily without moving market. When there's confirmation of reasonable (~50%) clean energy usage by miners with positive future trend, Tesla will resume allowing Bitcoin transactions." 3. When the U.S. Food and Drug Administration approved Aduhelm, Biogen's (BIIB) Alzheimer's disease therapy, this past Monday, it did so on the basis of the drug's ability to reduce the level of junk proteins in patients' brains, Josh Nathan-Kazis wrote in this week's edition of Barron's. The agency believes that clearing those proteins, called amyloid plaques, reduces cognitive decline, he added, noting that the move now opens the possibility of approvals for other drugs that, like Aduhelm, can clear amyloid plaque, but haven't been proven definitively to slow cognitive decline. Eli Lilly's (LLY) donanemab is one. Gantenerumab, from Roche Holding (RHHBY), is another. Biogen and its partner, Eisai (ESALY), have a third, known as BAN2401. 4. ViacomCBS (VIAC) subsidiary Paramount's "A Quiet Place II" won this weekend's box office with a surprising $11.7M for a domestic total of about $109M. The horror movie is the first in the pandemic era to cross the $100M mark domestically. 5. UPS (UPS) and DocuSign (DOCU) saw positive mentions in this week's edition of Barron's.